Fig. S1
Relative growth factor concentration of collected media conditioned by iPSC-ECs within SHIELD at 4 days post-injection
Fig. S2
Improvement in blood perfusion in the ischemic hindlimb after hiPSC-EC transplantation. Perfusion ratio (value of the ischemic limb divided by that of the non-ischemic limb) of ischemic limbs following treatment with PBS, SHIELD-2.5, iPSC-ECs in PBS, or iPSC-ECs in SHIELD-2.5. Table S1 Amino acid sequences for the peptide and protein components of SHIELD shown using singleletter amino acid codes. The symbols for the various components correspond with the symbols used in Figure 1a . For the recombinant engineered protein C7, the WW domain is listed in blue, the cell-adhesive RGDS sequence is bold (black), and the hydrophilic spacer regions in black.
Table S2
Material formulation for SHIELD family of hydrogels.
